Four genomic screens for linkage in multiple sclerosis (MS) 
Introduction
Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system. Genetic epidemiology has clearly shown the importance of genetic factors in MS. 1 Published genomic screens in MS have confirmed the already well established role of the human leucocyte antigen (HLA) complex genes in MS and, in addition, suggested the importance of a few other chromosomal segments. [2] [3] [4] [5] Subsequently, some of these regions, ie 6p, 5p, 17q, 7p, 7q, 12p and 12q, have received additional support in studies in Nordic populations showing modestly positive linkage scores. [6] [7] [8] [9] 3p14-13 is another locus identified in previous genomic screens. Thus, Sawcer et al 2 reported a lod score of approximately 1.0 between markers D3S1289 and D3S1261 in a UK MS screen whereas Ebers et al 4 a 59% sharing of marker D3S1261 between Canadian affected MS sibling pairs, which equals a maximum lod score (MLS) of 0.99. Interestingly, marker D3S1573, which is 0.5 cM away from D3S1289, has shown evidence for linkage with Crohn's disease, another supposedly autoimmune disorder, with a lod-score of 2.69. 10 Within this region, the spinocerebellar ataxia 7 (SCA7) gene is located. In this gene, an expanded CAG repeat sequence causes a progressive central nervous system (CNS) disease sharing some features with MS, justifying a role for this gene as a candidate gene in MS.
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Results
Linkage analysis
Linkage analysis with eight microsatellite markers in 3p14-13 region had been carried out in 146 Nordic multiplex MS families. Results from two-point non-parametric linkage (NPL) analysis are shown in Table 1 , whereas multipoint results are shown in Figure 1 . In short, suggestive linkage was found for the D3S1285 marker by two-point linkage analysis according to the critical value suggested by Lander and Kruglyak. 12 However, there were also strikingly high NPL scores for markers flanking this region, including markers at the centromeric region. This prompted us to make separate analyses for the two larger ethnic subgroups within the material. Thus, among the 61 Swedish families, positive scores (NPL = 1.2) were also noted for the D3S1573 marker, 20 cM telomeric to D3S1285 whereas the 59 Danish families revealed not positive for this marker. In contrast, whereas the two-point NPL-score for the Danish families was positive (NPL = 1.32) for the D3S1285 marker, the multipoint NPL plot shows neutral scores that gradually increase going further centromeric (data not shown). This may be the explanation for our failure to delineate the region of interest, even if our markers covered as much as 36 cM, no clear ends of the peak could be identified. However, it should be kept in mind that there was no significant evidence for heterogeneity, which limits the value of such an analysis. A few marker alleles showed modestly significant transmission disequilibrium with the disease locus when analyzed by the transmission disequilibrium test (TDT) (data not shown). Considering the large number of alleles tested, none of these deviations were very striking.
Association analysis
In addition to linkage analysis, we also investigated for possible association between marker alleles and sporadic MS. Only one allele, of marker D3S2465, showed significant association (P Ͻ 0.05), albeit before correction for multiple comparisons. When looking for agreements between the TDT and association analyses, both focusing on the importance of specific marker alleles, no marker alleles were found to be associated with MS as well as showing significant excess transmission to MS patients.
Genotyping for the SCA7 gene trinucleotide repeat sequence did not detect expansions in index cases from 15 families.
Discussion
We have observed suggestive evidence for linkage with 3p14-13, thereby adding to the evidence that this locus may harbor one or several factors that contribute to the genetically determined susceptibility to MS. Similar indications were previously reported for markers in this region in one British and one Canadian genome-wide search.
Although initial responses to the publication of three genomic screens in MS [2] [3] [4] were disappointing in failing to identify strong or consistent loci apart from the HLA complex and a possible locus on chromosome 5, recent data have been more inspiring. In particular, investigations of populations in northern Europe have been rewarding. Thus, Kuokkanen and co-workers 5, 13 confirmed the importance of both the 5p locus and a region on 17q indicated already in the British genomic screen. 2 Recently, Oturai et al, 6 reported suggestive evidence for the importance of both these loci in a set of jointly collected Scandinavian families, also, in part, forming the basis for this study.
In addition, Xu et al 8 working on Swedish families has reported similarly weak but positive data for two loci; 7p15, originally indicated to be of importance by data from the British and Canadian screens, 2,4 and 12q23, identified in the American screen. 3 Of these, the 7p15 locus has also been given support in an Italian study. 14 Also two other loci syntenic to autoimmune animal model diseases show promising linkage to MS susceptibility. 9 The observation by Becker et al, 15 that non-major histocompatibility complex (MHC) loci from different inflammatory or autoimmune diseases, both human and experimental animal models, tend to overlap, adds to the impression that these loci may in fact be of true importance.
Genetic heterogeneity is generally assumed to be frequent in polygenic disorders such as MS. Most importantly, it serves as an explanation for the absence of a strong single genetic factor and the failure of linkage analysis, be it genome-wide or focused on specific genes, to produce formally significant evidence. In fact, it has even been difficult to produce significant lod-scores for the HLA class II region, which is confirmed to be associated with MS in numerous studies (for a review, see Hillert 16 ). Therefore, it may be crucial to base MS linkage analysis on populations where a higher degree of homogeneity may be expected. The success in a limited number of Finish families (n = 21) to display significant lodscores for both HLA, 5p and 17q, may be the best example of this. 5, 17 Supposed homogeneity was also the reason for an effort to collect a common set of Scandinavian affected MS sibling pairs, of which 124 are analyzed in this study. In fact, the current data, as well as data previously reported, 6, 8 are not clearly evidence for the success of this approach. On one hand, the support for several previously suggested loci would not have been possible without some homogeneity, but on the other hand, linkage scores are by no means higher than in previous screens on more 'outbred' populations. Thus, a true benefit from genetic homogeneity may require the collection of families from populations even smaller than the Nordic (the joint population of the Nordic countries is approximately 25 million). Most importantly, it suggests that even in small populations, the genetic risk for MS is determined by several genes rather than by a few. Anyhow, the scores for 3p14-13 are the highest noted so far for any non-HLA locus in the joint Nordic material.
In conclusion, this study adds to the impression that there may be relevant genes with an importance for MS in 3p14-13 as in other loci that have been indicated by previous genomic screens. The modest efforts to identify transmission disequilibrium and association among those used for linkage analysis were, as expected, not successful, due to the size of the region and the low number of markers investigated. Thus, further attempts to delineate this locus and to establish associations are warranted although the prospects of eventual success of this strategy may be discussed. 18 
Genes and Immunity
Materials and methods
Subjects
In all, 146 MS families from the Nordic countries were investigated: 61 from Sweden, 59 from Denmark, 12 from Norway and 14 from Finland. Among them, 124 were affected sib-pair families and the remaining 22 were Swedish mutiplex families containing a mixture of other affected relative pairs (see Table 2 ). A total of 190 Swedish sporadic MS patients and 148 ethnically-matched normal controls were used in an additional association study. Index cases from 15 Swedish sib-pair families were chosen for the analysis of possible expansions of the SCA7 genes.
All patients were diagnosed according to the Poser criteria. 19 MS patients were examined or had their medical records reviewed by one of the authors. Only clinically definite MS patients were considered as affected and included in the study. The study was approved by the local ethics committee.
Markers and genotyping
Eight markers were selected, covering 36 cM around the region of interest. The marker order and distances were collected from the LDB integrated map (http:// cedar.genetics.soton.ac.uk/publicFhtml/gmap.html). Allele frequencies used in the analysis were obtained either from the founders of the families or from the group of healthy controls.
Genomic DNA was extracted from peripheral blood leukocytes using standard procedure. 20 Polymerase chain reaction (PCR) was employed in 7 l reaction volumes. In all, 865 individuals were genotyped for eight microsatellite markers. Four markers were taken from the Weber 6 panel and the rest primer pairs were synthesized at Cybergene Synthesis Company (Huddinge, Sweden). Forward primers for each primer pair were labeled with 5Ј-FAM, HEX, or TET phosphoramides. Optimal PCR conditions were 95°C for 30 s, 55°C for 30 s and 72°C for 40 s with 30 cycles in a PCR Cycler 9600 (Perkin Elmer), but varied slightly for a few markers. PCR products were diluted and pooled, 0.5 l of mixture was combined with 1.5 l internal lane size standard mixture (Genescan −350 or −500 TAMRA, Applied BioSystems). Genotyping was carried out using fluorescently labeled oligonucleotides in the semiautomatic GENESCAN/GENOTYPER system on a 377 DNA sequencing equipment (Applied BioSystems). 
Statistical analysis
Linkage analysis: Since the mode of inheritance for MS is unknown and simple Mendelian models are less likely to be adequate in a polygenic disorder, nonparametric linkage analyses were chosen. Both two-point and multipoint NPL analysis were calculated using the GENEHUNTER software, version 2.0. 21 The NPL score is model-independent and effectively measures the extent of which marker alleles are shared identical-by-descent between affected individuals more often than expected under random segregation. It was chosen also as it is suitable for families with more than one affected member, either sibpairs or other relative pairs.
Transmission disequilibrium test:
In the families, we used the extended transmission disequilibrium test (ETDT) version 1.4, 22 which is a family-based linkage-disequilibrium test that offers a test for linkage between alleles and phenotypes that is either causal (ie, the marker is the disease/trait polymorphism) or due to linkage disequilibrium.
Population-based association study: Chi-square analysis was applied in the association study.
